Cambridge, MA, October 13, 2022 -- Carmine Therapeutics (“Carmine”), an EVX founded biotech company and emerging leader in non-viral gene...

CAMBRIDGE, Mass., May 5, 2021 /PRNewswire/ -- Carmine Therapeutics, Inc., an emerging leader in gene therapy, today announced that Don...

Cambridge, MA / 28 Sep 2020 – Carmine Therapeutics announced today that it has been named by FierceBiotech as one of 2020’s Fierce 15...

A warm welcome to Professor Mark Kay MD, PhD to our Scientific Advisory Board! His renowned expertise in gene therapy will provide...

Carmine Therapeutics and Takeda Collaborate to Discover and Develop Rare Disease Gene Therapies Using Novel RBCEVs Platform.

Carmine Therapeutics is proud to announce that it has won the Bristol-Myers Squibb’s 2019 Golden Ticket for LabCentral.